At the WHO Hub for Pandemic and Epidemic Intelligence, an international team of scientists and public health experts work to protect communities - across the world and here in Germany - from health emergencies, in particular from the impacts of…
The Berlin-based start-up Cambrium uses artificial intelligence to produce bio-based materials. The materials are sustainable and above all - depending on the use case - adaptable to the respective purpose.
So far, research across medical health institutions has been complicated in Germany – not least because it was difficult to obtain relevant and comparable data. In the future, things will get easier for researchers. Of late, they have been able to…
BeCAT - The therapy of the future is developed here
At Charité's "Berlin Center for Advanced Therapies" (BeCAT), the new class of Advanced Therapy Medicinal Products (ATMP) has been under development since 2018. In 2024, it will move into the new…
Another center for cutting-edge research in medicine is being built in Berlin. The new building, called "Der Simulierte Mensch" (Si-M), will provide space for around 140 researchers from science and clinical practice to carry out their scientific…
The Berlin-based company Ariceum Therapeutics is focusing on radiopharmaceuticals in its fight against difficult-to-treat cancers. It is planned that corresponding products will be brought into registration or approved in 2028. Ariceum is well on the…
Berlin-Brandenburg is one of the leading international life science locations. Here and throughout Germany, the healthcare industry is growing steadily. Suitable areas for research and development as well as production will therefore be needed more…
February 28 is ‘rare disease day’ – an awareness day for all people who suffer from such a rare disease. An important contact point for them in the airport region Berlin Brandenburg is the Berlin Center for Rare Diseases (BCSE) of the Charité –…
Takeda, the global biopharmaceutical company, has a history of more than 240 years rich in tradition and always characterized by further development and innovation. In Germany, however, the focus of Takeda is not only on shaping progress in the…
Numerous parameters are measured for patients in the intensive care unit. The AI-based software from x-cardiac GmbH uses this data to calculate whether serious complications will occur. The doctors can then intervene before damage occurs. After…
